Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts

Paolo Strati; Guillermo Garcia-Manero; Chong Zhao; Tapan Kadia; Gautam Borthakur; Marina Konopleva; Naval Daver; Courtney D. DiNardo; Nicholas J. Short; Musa Yilmaz; Kiran Naqvi; Yesid Alvarado; Sherry A. Pierce; Jorge Cortes; Carlos Bueso-Ramos; Hagop Kantarjian; Farhad Ravandi

doi:10.1002/ajh.25490

Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts

Paolo Strati, Guillermo Garcia-Manero, Chong Zhao, Tapan Kadia, Gautam Borthakur, Marina Konopleva, Naval Daver, Courtney D. DiNardo, Nicholas J. Short, Musa Yilmaz, Kiran Naqvi, Yesid Alvarado, Sherry A. Pierce, Jorge Cortes, Carlos Bueso-Ramos, Hagop Kantarjian, Farhad Ravandi

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	E188-E190
Journal	American journal of hematology
Volume	94
Issue number	7
DOIs	https://doi.org/10.1002/ajh.25490
State	Published - Jul 2019

ASJC Scopus subject areas

Hematology

MD Anderson CCSG core facilities

Clinical Trials Office

Access to Document

10.1002/ajh.25490

Cite this

Strati, P., Garcia-Manero, G., Zhao, C., Kadia, T., Borthakur, G., Konopleva, M., Daver, N., DiNardo, C. D., Short, N. J., Yilmaz, M., Naqvi, K., Alvarado, Y., Pierce, S. A., Cortes, J., Bueso-Ramos, C., Kantarjian, H., & Ravandi, F. (2019). Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts. American journal of hematology, 94(7), E188-E190. https://doi.org/10.1002/ajh.25490

Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts. / Strati, Paolo ; Garcia-Manero, Guillermo; Zhao, Chong et al.
In: American journal of hematology, Vol. 94, No. 7, 07.2019, p. E188-E190.

Research output: Contribution to journal › Letter › peer-review

Strati, P , Garcia-Manero, G, Zhao, C, Kadia, T , Borthakur, G, Konopleva, M, Daver, N , DiNardo, CD , Short, NJ , Yilmaz, M, Naqvi, K, Alvarado, Y, Pierce, SA, Cortes, J, Bueso-Ramos, C , Kantarjian, H & Ravandi, F 2019, 'Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts', American journal of hematology, vol. 94, no. 7, pp. E188-E190. https://doi.org/10.1002/ajh.25490

@article{1b8374be0eeb4b1d9ced5749e922d61c,

title = "Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts",

author = "Paolo Strati and Guillermo Garcia-Manero and Chong Zhao and Tapan Kadia and Gautam Borthakur and Marina Konopleva and Naval Daver and DiNardo, {Courtney D.} and Short, {Nicholas J.} and Musa Yilmaz and Kiran Naqvi and Yesid Alvarado and Pierce, {Sherry A.} and Jorge Cortes and Carlos Bueso-Ramos and Hagop Kantarjian and Farhad Ravandi",

note = "Funding Information: This research is supported in part by the MD Anderson Cancer Center Support Grant P30 CA016672. Funding Information: This research is supported in part by the MD Anderson Cancer Center",

year = "2019",

month = jul,

doi = "10.1002/ajh.25490",

language = "English (US)",

volume = "94",

pages = "E188--E190",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "7",

}

TY - JOUR

T1 - Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts

AU - Strati, Paolo

AU - Garcia-Manero, Guillermo

AU - Zhao, Chong

AU - Kadia, Tapan

AU - Borthakur, Gautam

AU - Konopleva, Marina

AU - Daver, Naval

AU - DiNardo, Courtney D.

AU - Short, Nicholas J.

AU - Yilmaz, Musa

AU - Naqvi, Kiran

AU - Alvarado, Yesid

AU - Pierce, Sherry A.

AU - Cortes, Jorge

AU - Bueso-Ramos, Carlos

AU - Kantarjian, Hagop

AU - Ravandi, Farhad

N1 - Funding Information: This research is supported in part by the MD Anderson Cancer Center Support Grant P30 CA016672. Funding Information: This research is supported in part by the MD Anderson Cancer Center

PY - 2019/7

Y1 - 2019/7

UR - http://www.scopus.com/inward/record.url?scp=85065166158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065166158&partnerID=8YFLogxK

U2 - 10.1002/ajh.25490

DO - 10.1002/ajh.25490

M3 - Letter

C2 - 30977182

AN - SCOPUS:85065166158

SN - 0361-8609

VL - 94

SP - E188-E190

JO - American journal of hematology

JF - American journal of hematology

IS - 7

ER -

Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Cite this